mesna - Profile
✉ Email this page to a colleague
What are the generic drug sources for mesna and what is the scope of freedom to operate?
Mesna
is the generic ingredient in two branded drugs marketed by Eugia Pharma, Fresenius Kabi Usa, Gland, Hikma, Mylan Institutional, Rising, Sagent Pharms Inc, Teva Pharms Usa, Baxter Hlthcare, and Ingenus Pharms Llc, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.Summary for mesna
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 10 |
| NDAs: | 11 |
US Patents and Regulatory Information for mesna
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | MESNA | mesna | INJECTABLE;INTRAVENOUS | 220518-001 | Jan 27, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Fresenius Kabi Usa | MESNA | mesna | INJECTABLE;INTRAVENOUS | 075811-001 | Apr 26, 2001 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Gland | MESNA | mesna | INJECTABLE;INTRAVENOUS | 206992-001 | Dec 18, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | MESNA | mesna | INJECTABLE;INTRAVENOUS | 075739-001 | Jan 9, 2004 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mylan Institutional | MESNA | mesna | INJECTABLE;INTRAVENOUS | 076488-001 | Mar 8, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for mesna
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | MESNEX | mesna | INJECTABLE;INTRAVENOUS | 019884-001 | Dec 30, 1988 | ⤷ Start Trial | ⤷ Start Trial |
| Baxter Hlthcare | MESNEX | mesna | TABLET;ORAL | 020855-001 | Mar 21, 2002 | ⤷ Start Trial | ⤷ Start Trial |
| Baxter Hlthcare | MESNEX | mesna | TABLET;ORAL | 020855-001 | Mar 21, 2002 | ⤷ Start Trial | ⤷ Start Trial |
| Baxter Hlthcare | MESNEX | mesna | INJECTABLE;INTRAVENOUS | 019884-001 | Dec 30, 1988 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
